Acrux Limited (AU:ACR) has released an update.
Acrux Limited, a specialty pharma company, announced its participation in the ASX Small and Mid Cap Conference, where CEO Michael Kotsanis will present on September 25. The company, known for developing and commercializing topical pharmaceutical products, invites collaboration and is exploring opportunities for commercial partnerships and product development. Acrux has a history of successfully marketing products, particularly in the U.S., and is leveraging its expertise to bring affordable topical generics to market.
For further insights into AU:ACR stock, check out TipRanks’ Stock Analysis page.
